Symptoms of Low Krill Oil: Causes, Treatment, and the Evidence
Deficiency
Symptoms & causes
Krill oil is not a nutrient — no deficiency syndrome exists — it is an alternative source of EPA and DHA omega-3 fatty acids delivered in phospholipid form with added astaxanthin; the claimed superior bioavailability over fish oil is a marketing advantage that is not consistently supported in head-to-head trials, and krill oil delivers far fewer milligrams of EPA+DHA per capsule at substantially higher cost.
There is no such thing as a krill oil deficiency. Krill oil is a supplement, not an essential nutrient — it provides the same EPA and DHA omega-3 fatty acids found in fish oil, delivered in a phospholipid form that may be slightly better absorbed and is less likely to cause fishy aftertaste. This page cuts through the marketing claims to examine the real evidence on bioavailability, the sub-therapeutic astaxanthin dose, the overlooked choline content, and the practical cost comparison — so you can decide whether krill oil is worth the premium over standard fish oil or algae oil.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Krill oil — oil extracted from Antarctic krill (Euphausia superba), small crustaceans at the base of the marine food chain. Primary bioactives: EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — delivered in phospholipid form (primarily phosphatidylcholine and phosphatidylethanolamine) rather than the triglyceride form in standard fish oil; astaxanthin — a red carotenoid antioxidant naturally present in krill; choline (from phosphatidylcholine). Typical krill oil capsule (500 mg): approximately 80–120 mg EPA + 40–75 mg DHA; compare to standard fish oil capsule (1,000 mg): approximately 180–300 mg EPA + 120–200 mg DHA. Thus krill oil typically delivers 40–60% of the EPA+DHA per capsule at approximately 2–3× the cost. No RDA or deficiency syndrome.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Not applicable — no krill oil deficiency phenotype exists. Searchers likely have omega-3 insufficiency concerns: dry skin, dry eyes, elevated triglycerides, joint stiffness — see the fish oil and omega-3 page for clinical framing of omega-3 deficiency.
Don't wait
See a doctor if
- Hypertriglyceridemia, cardiovascular risk factors, or inflammatory conditions warrant clinical evaluation; omega-3 status can be measured via the omega-3 index (EPA+DHA as percentage of red blood cell fatty acids)
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- No deficiency population exists for krill oil. Populations that may choose krill oil over fish oil include: people sensitive to fish oil burp-back and aftertaste, people seeking higher-convenience dosing with fewer capsules, people attracted to the astaxanthin content, and people who have tried standard fish oil and found it intolerable. People with shellfish allergy must not use krill oil — krill are crustaceans and this is an absolute contraindication.
What causes low Krill oil — oil extracted from Antarctic krill (Euphausia superba), small crustaceans at the base of the marine food chain. Primary bioactives: EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — delivered in phospholipid form (primarily phosphatidylcholine and phosphatidylethanolamine) rather than the triglyceride form in standard fish oil; astaxanthin — a red carotenoid antioxidant naturally present in krill; choline (from phosphatidylcholine). Typical krill oil capsule (500 mg): approximately 80–120 mg EPA + 40–75 mg DHA; compare to standard fish oil capsule (1,000 mg): approximately 180–300 mg EPA + 120–200 mg DHA. Thus krill oil typically delivers 40–60% of the EPA+DHA per capsule at approximately 2–3× the cost. No RDA or deficiency syndrome.
- Not applicable — krill oil is a supplement, not an essential nutrient. There is no krill oil deficiency state. The underlying concern is omega-3 insufficiency from inadequate dietary intake of fatty fish or supplementation.
How low levels are diagnosed
Omega-3 index — EPA+DHA as percentage of red blood cell fatty acids — is the same measurement used for fish oil status. Optimal is greater than 8%, and high risk is less than 4%. This measures omega-3 tissue status regardless of whether the source is krill oil, fish oil, algae oil, or dietary fatty fish.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Not applicable for deficiency. Typical doses in krill oil trials range from 1–3 grams per day of krill oil. Note that 3 grams of krill oil delivers only approximately 300–450 mg of EPA+DHA, equivalent to what is achievable with 1 gram of concentrated fish oil. For omega-3 therapeutic doses in hypertriglyceridemia, krill oil is impractical — prescription EPA/DHA formulations at 4 grams per day would require 15–20 or more krill oil capsules. Shellfish allergy is a firm contraindication for krill oil.
How to keep levels up
Not applicable for krill oil specifically. Dietary fatty fish at two or more servings per week remains the most evidence-backed way to maintain omega-3 status, per the American Heart Association. Supplementation with any EPA/DHA source — fish oil, krill oil, or algae oil — can fill gaps when dietary intake is insufficient.
When to see a clinician
For omega-3 status assessment and cardiovascular or inflammatory management, clinical guidance is appropriate — as with fish oil. Shellfish allergy patients must not use krill oil and should discuss algae-based alternatives with their provider. Anticoagulant users must disclose krill oil use to their prescriber due to the same antiplatelet mechanism as fish oil.
Krill Oil vs. Fish Oil: The Phospholipid Bioavailability Debate and What the Evidence Shows
The central marketing claim for krill oil is that its phospholipid-bound EPA and DHA is absorbed far more efficiently than the triglyceride-bound form in standard fish oil — meaning you need less to get the same blood levels. The reality is more modest and inconsistent than the marketing suggests.
Some trials do show a small advantage. A 2011 study by Schuchardt and colleagues found that 543 mg of EPA+DHA from krill oil achieved similar plasma levels as 864 mg from fish oil, suggesting roughly 1.5× greater efficiency. However, the sample size was small and the crossover design had limitations that make the finding suggestive rather than definitive.
Other studies found no meaningful difference. Ulven and colleagues compared krill oil and fish oil at equivalent EPA+DHA doses over seven weeks and found no significant difference in how much EPA and DHA was incorporated into red blood cell phospholipids — the gold-standard measure of omega-3 status. A 2020 meta-analysis reached the same conclusion: at equivalent EPA+DHA doses, krill oil and fish oil produce similar increases in plasma and red blood cell omega-3 levels.
The honest takeaway is that any bioavailability advantage is small — perhaps 1.2–1.5× in the most favorable studies — not the dramatic 2–5× improvement that krill oil marketing often implies. The phospholipid form does have one real, practical advantage: it is significantly less prone to causing the fishy burp-back and GI distress that some people experience with standard fish oil.
- Phospholipid form: EPA and DHA bound to phosphatidylcholine rather than triglycerides
- Best-case evidence: ~1.5× greater efficiency in one small trial — not consistently replicated
- Meta-analysis conclusion: equivalent EPA+DHA doses produce similar blood levels regardless of form
- Real advantage: reduced fishy aftertaste and GI distress compared to standard fish oil
Bottom line
Krill oil's claimed phospholipid bioavailability advantage is supported by some trials but is inconsistent in the literature and modest at best — the dramatic 'requires less' marketing claim is not validated in meta-analysis.
Astaxanthin: The Antioxidant in Krill Oil and Its Independent Evidence
Astaxanthin is the red carotenoid pigment that gives krill, salmon, and flamingos their color — and it is a genuinely potent antioxidant. In laboratory studies, astaxanthin demonstrates far greater free-radical-scavenging capacity than vitamin E or beta-carotene. Human trials have explored astaxanthin for exercise recovery, skin photoprotection, and metabolic inflammation — with some promising but preliminary results.
The problem is the dose. A typical 500 mg krill oil capsule contains approximately 0.1–0.2 mg of astaxanthin. The doses studied in the better human astaxanthin trials are 4–12 mg per day — roughly 20 to 60 times more than what you get from a single krill oil capsule. To reach 4 mg of astaxanthin from krill oil alone, you would need to take 20 or more capsules daily.
This does not mean the astaxanthin in krill oil is worthless — it contributes to the oil's oxidative stability and provides a small antioxidant bonus. But if astaxanthin's specific benefits are what you are after, dedicated astaxanthin supplements at studied doses are a far more practical and cost-effective approach than trying to get a therapeutic dose through krill oil.
The astaxanthin content is frequently highlighted in krill oil marketing as a key differentiator from fish oil. In reality, it is a nutritional footnote — a nice bonus at best, not a reason to choose krill oil over other omega-3 sources.
- Astaxanthin dose in krill oil: ~0.1–0.2 mg per 500 mg capsule
- Studied therapeutic doses: 4–12 mg per day in human trials
- To reach 4 mg from krill oil: would require 20+ capsules daily
- Astaxanthin's role in krill oil: primarily oxidative stability of the oil, not therapeutic effect
Bottom line
Krill oil contains astaxanthin at sub-therapeutic doses — roughly 0.2 mg per capsule versus the 4–12 mg per day used in clinical trials — making the astaxanthin content a marketing advantage rather than a meaningful clinical dose at normal krill oil supplement use.
The Choline Advantage: An Overlooked Krill Oil Nutrient With Genuine Value
Krill oil's least marketed but potentially most distinctive advantage is its choline content. Because krill oil delivers EPA and DHA bound to phosphatidylcholine, each capsule provides a small but meaningful dose of choline — a nutrient that roughly 90% of Americans do not consume at adequate levels according to NHANES data.
Choline is essential for several critical functions: it is a precursor to acetylcholine, the neurotransmitter involved in memory and muscle control; it is required for cell membrane integrity through phosphatidylcholine synthesis; it serves as a methyl donor in the methionine cycle alongside folate and vitamin B12, which is relevant for homocysteine metabolism and DNA methylation; and it is necessary for VLDL assembly and the export of fat from the liver. Inadequate choline intake is a known driver of hepatic fat accumulation and non-alcoholic fatty liver disease.
A typical 500 mg krill oil capsule provides approximately 30–60 mg of choline. This is a meaningful contribution toward the Adequate Intake of 550 mg per day for men and 425 mg per day for women, but it is not sufficient on its own to correct a deficient diet. The choline content is best understood as a modest nutritional bonus that distinguishes krill oil from standard fish oil, which contains negligible choline.
The NAFLD connection is particularly relevant for people considering or using GLP-1 medications. NAFLD is highly prevalent in the GLP-1 candidate population, and choline deficiency worsens hepatic fat accumulation. While no trial has tested krill oil specifically in GLP-1-treated NAFLD patients, the choline content provides a plausible, if modest, complementary mechanism alongside GLP-1's metabolic effects on liver fat.
- Choline per 500 mg krill oil capsule: ~30–60 mg
- Choline Adequate Intake: 550 mg/day (men), 425 mg/day (women)
- ~90% of Americans do not meet the choline AI
- Choline's role: liver fat export, acetylcholine synthesis, methylation, membrane integrity
- NAFLD relevance: choline deficiency drives hepatic fat accumulation — modest complementary support for GLP-1 patients
Bottom line
Krill oil's phosphatidylcholine content provides a small dose of choline — a nutrient that 90% of Americans are below the Adequate Intake for, relevant to liver fat metabolism and the NAFLD context of GLP-1 patients; this is krill oil's most clinically distinctive, if modest, advantage over standard fish oil.
Cost, Sustainability, and Practical Comparison: Krill Oil vs. Fish Oil vs. Algae Oil
The consumer decision between krill oil, fish oil, and algae oil comes down to three practical factors: cost per milligram of EPA and DHA, sustainability, and tolerability. Honest content should lay out the numbers so you can make an informed choice.
On cost, the difference is stark. Krill oil typically costs approximately $0.20–0.50 per 100 mg of EPA+DHA, while concentrated fish oil costs approximately $0.05–0.10 per 100 mg. Algae oil, which provides DHA and sometimes EPA without fish or shellfish sources, falls in between at roughly $0.15–0.30 per 100 mg of DHA. Even if krill oil's phospholipid form provides a modest 1.2–1.5× bioavailability advantage, the cost per bioavailable milligram of omega-3 still favors concentrated fish oil by a wide margin.
On sustainability, major krill oil brands are Marine Stewardship Council certified, meaning the fishery meets current sustainability standards. However, Antarctic krill is the foundation of the Southern Ocean food web — whales, penguins, seals, and seabirds depend on it. The ecological concern is not about krill extinction but about localized depletion affecting predator populations, and this remains a legitimate consideration for environmentally conscious consumers. Algae oil carries no such concerns and is the most sustainable option.
On tolerability, krill oil has a genuine advantage. The phospholipid form is significantly less prone to causing the fishy burp-back and GI distress that some people experience with triglyceride-based fish oil. For people who have tried fish oil and found it intolerable, krill oil is a reasonable alternative. For vegans and people with shellfish allergy, algae oil is the correct choice — it provides biologically equivalent DHA and EPA without any animal-derived ingredients or crustacean allergens.
- Cost per 100 mg EPA+DHA: krill oil ~$0.20–0.50, fish oil ~$0.05–0.10, algae oil ~$0.15–0.30
- Sustainability: MSC-certified krill fisheries exist, but ecological concerns about Antarctic food web impacts remain
- Tolerability: krill oil causes less fishy aftertaste and GI distress than standard fish oil — a real practical advantage
- Shellfish allergy: krill oil is contraindicated — algae oil is the safe alternative
- Vegan option: algae oil provides DHA and EPA without animal sources
Bottom line
Krill oil costs 2–5× more per milligram of EPA+DHA than concentrated fish oil — the bioavailability advantage does not fully offset the cost difference; for vegans and shellfish allergy patients, algae oil is the correct alternative to both.
Krill Oil and GLP-1 Therapy: Choline, NAFLD, and the Shellfish Allergy Warning
For people using GLP-1 medications, krill oil presents a mixed picture of modest benefits and important cautions. The most practical advantage is tolerability: GLP-1 medications frequently cause nausea and GI sensitivity, especially during dose escalation, and krill oil's phospholipid form is less likely to trigger fishy burping or stomach upset than standard triglyceride fish oil. If omega-3 supplementation is indicated, krill oil may simply be easier to tolerate during the early months of GLP-1 therapy.
The choline-NAFLD connection is the most clinically interesting angle. GLP-1 receptor agonists are increasingly studied for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis — semaglutide has demonstrated reductions in liver fat content in NASH clinical trials. Choline deficiency is a known contributor to hepatic fat accumulation because choline is required for VLDL assembly and fat export from the liver. Krill oil's phosphatidylcholine content provides a small choline bonus that may be complementary to GLP-1's effects on liver fat, though no trial has tested this combination directly.
The cautions are critical. Krill oil carries the same anticoagulant interaction as fish oil — at supplement doses, it inhibits platelet aggregation and can increase bleeding risk when combined with warfarin, clopidogrel, or aspirin. GLP-1 patients on any blood-thinning medication must disclose krill oil use to their prescriber. More importantly, shellfish allergy is an absolute contraindication for krill oil. Krill are crustaceans, and the proteins that trigger shellfish allergic reactions can be present in krill oil. GLP-1 patients, who are often managing multiple health conditions, should have their allergy status screened before considering krill oil.
The bottom line for GLP-1 users: if you need omega-3 supplementation and find fish oil intolerable due to nausea or burp-back, krill oil is a reasonable alternative with a modest choline bonus — but it costs more per milligram of EPA and DHA, and it is absolutely off-limits if you have a shellfish allergy.
- GI tolerability: phospholipid form causes less nausea and fishy aftertaste — meaningful for GLP-1 patients
- NAFLD context: choline from phosphatidylcholine may modestly support liver fat metabolism alongside GLP-1 therapy
- Anticoagulant interaction: same as fish oil — must disclose to prescriber if on blood thinners
- Shellfish allergy: absolute contraindication — krill are crustaceans; use algae oil instead
- No direct GLP-1-krill oil interaction trials exist — recommendations are based on mechanism and practical rationale
Bottom line
Krill oil's best practical advantage for GLP-1 patients is GI tolerability over standard fish oil — relevant because GLP-1 nausea is already a burden; the choline content is a modest NAFLD bonus; shellfish allergy is an absolute contraindication that must be screened at intake.
What most pages leave out
Krill oil marketing consistently presents the phospholipid bioavailability advantage as proven and dramatic (2–5× better) — meta-analysis does not support this at equivalent EPA+DHA doses; krill oil provides far fewer omega-3 milligrams per capsule at 2–3× the cost; astaxanthin content is sub-therapeutic for any claimed astaxanthin benefit; the shellfish allergy contraindication is frequently not mentioned. Algae oil is rarely mentioned as a superior vegan alternative to both fish and krill oil.
We flag this so you can make an informed choice — not to scare you off.
Frequently Asked Questions
None — krill oil is a supplement, not a nutrient. The underlying concern is omega-3 (EPA/DHA) insufficiency, which can cause dry skin, elevated triglycerides, joint stiffness, and in infants, visual and cognitive impairment. There is no recognized clinical deficiency syndrome for krill oil or any unique krill-derived compound.
Krill oil's phospholipid form may be absorbed slightly more efficiently — some trials suggest a modest 1.2–1.5× advantage — and it is less likely to cause fish-burp aftertaste. However, it delivers far fewer milligrams of EPA+DHA per capsule at 2–3× the cost. For equivalent omega-3 intake, concentrated fish oil is more cost-effective.
No. Krill are crustaceans, and krill oil is contraindicated in shellfish allergy. The proteins that trigger shellfish allergic reactions can be present in krill oil. Algae-based EPA/DHA supplements are a safe, vegan alternative for people with shellfish allergies.
Yes, krill oil naturally contains astaxanthin — approximately 0.1–0.2 mg per 500 mg capsule. This is well below the 4–12 mg per day doses studied for astaxanthin's benefits on skin, exercise recovery, and inflammation in clinical trials. The astaxanthin in krill oil is a nutritional bonus, not a therapeutic dose.
Yes. Like fish oil, krill oil at supplement doses inhibits platelet aggregation and can increase bleeding risk when combined with anticoagulants such as warfarin or antiplatelet agents like aspirin and clopidogrel. You must disclose krill oil use to your prescriber if you take any blood-thinning medication.
The EPA and DHA in krill oil can reduce triglycerides through the same mechanism as fish oil. However, for clinical hypertriglyceridemia requiring therapeutic omega-3 doses, the number of krill oil capsules needed would be impractical — prescription omega-3 formulations are the evidence-based choice.
Major commercial krill fishing operations are Marine Stewardship Council (MSC) certified, indicating they meet sustainability standards for wild-caught fisheries. However, ecological concerns about krill's role as the foundation of the Antarctic food web — supporting whales, penguins, and seals — remain a legitimate consideration for environmentally conscious consumers.
There is no direct evidence that krill oil reduces GLP-1-related nausea. However, krill oil's phospholipid form tends to cause less GI distress and fishy aftertaste than standard triglyceride fish oil. For GLP-1 patients who need omega-3 supplementation and experience GI sensitivity, krill oil may be a more tolerable alternative to fish oil.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Coconut Oil: Causes and Treatment
Coconut oil is a dietary fat, not an essential nutrient — no deficiency syndrome exists. Learn why major health authorities recommend limiting its saturated fat content.
Read moreSymptoms of Low Hemp Oil: Causes and Treatment
Hemp oil is a cooking oil, not a nutrient, and no deficiency syndrome exists. Learn the truth about hemp oil vs. CBD oil, its fatty acid profile, and skin health claims.
Read moreSymptoms of Low Evening Primrose Oil: Causes and Treatment
Evening primrose oil is not an essential nutrient, so no deficiency syndrome exists. Learn what EPO is actually used for, its evidence for eczema and PMS, and GLP-1 considerations.
Read moreSymptoms of Low Black Currant Seed Oil: Causes and Treatment
Black currant seed oil is not an essential nutrient, and no recognized deficiency exists. Learn why GLA is synthesized by the body and what the oil is actually used for.
Read moreSymptoms of Low Flaxseed Oil: Causes, Treatment, and ALA Deficiency
Flaxseed oil provides the essential omega-3 ALA, but true deficiency is rare. Learn the symptoms of low ALA intake, how it compares to fish oil, and proper use.
Read moreSymptoms of Low Cod Liver Oil: Causes and Treatment
There is no cod liver oil deficiency syndrome. Learn about the unique risks of vitamin A toxicity, how it differs from fish oil, and safe dosing practices.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you. Curex compounded semaglutide: $199/month equivalent prepaid annually ($2,388 upfront), or $299/month paid monthly. Compounded tirzepatide: $299/month equivalent prepaid annually ($3,588 upfront), or $399/month paid monthly. Commercial rates as of 2026-10-12; compounded products are not FDA-approved and clinical eligibility must be assessed.
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
- Prescription required, subject to provider review
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.